Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P R Fortin

Showing results (1-10 of 85) with videos related to

Pageof 9
Sort By:
Current Oncology (Toronto, Ont.)|September 5, 2008
How to put wellness on the prescription pad: recommendationsP R Fortin
The Journal of Rheumatology|January 1, 1992
Quality assurance in Canada: does insurance affect assurance?P R Fortin
Current Opinion in Rheumatology|January 1, 1996
Vasculitides associated with malignancyP R Fortin
Lupus|November 24, 1999
Recruitment strategies in superiority trials in SLE: lessons from the study of methotrexate in lupus erythematosus (SMILE)D Ferland, P R Fortin
Lupus|October 1, 1995
Response criteria for clinical trials in systemic lupus erythematosusM H Liang, P R Fortin
The Journal of Rheumatology. Supplement|January 11, 1992
Epidemiologic studies of rheumatoid arthritis: future directionsC W Heath, P R Fortin
The Journal of Rheumatology|November 1, 1995
Small changes in outpatients lupus activity are better detected by clinical instruments than by laboratory testsP R Fortin, M Abrahamowicz, D Danoff
AJR. American Journal of Roentgenology|November 1, 1990
Tuberculosis of the skullM A Miller, F Lebel, P R Fortin
Lupus|November 24, 1999
Discordance between patients and their physicians in the assessment of lupus disease activity: relevance for clinical trialsJ C Yen, C Neville, P R Fortin
Arthritis and Rheumatism|August 1, 1995
Measuring relevant change: an emerging challenge in rheumatologic clinical trialsP R Fortin, G Stucki, J N Katz
Pageof 9

Showing results (1-10 of 85) with videos related to

Sort By:
Pageof 9
Current Oncology (Toronto, Ont.)|September 5, 2008
How to put wellness on the prescription pad: recommendationsP R Fortin
The Journal of Rheumatology|January 1, 1992
Quality assurance in Canada: does insurance affect assurance?P R Fortin
Current Opinion in Rheumatology|January 1, 1996
Vasculitides associated with malignancyP R Fortin
Lupus|November 24, 1999
Recruitment strategies in superiority trials in SLE: lessons from the study of methotrexate in lupus erythematosus (SMILE)D Ferland, P R Fortin
Lupus|October 1, 1995
Response criteria for clinical trials in systemic lupus erythematosusM H Liang, P R Fortin
The Journal of Rheumatology. Supplement|January 11, 1992
Epidemiologic studies of rheumatoid arthritis: future directionsC W Heath, P R Fortin
The Journal of Rheumatology|November 1, 1995
Small changes in outpatients lupus activity are better detected by clinical instruments than by laboratory testsP R Fortin, M Abrahamowicz, D Danoff
AJR. American Journal of Roentgenology|November 1, 1990
Tuberculosis of the skullM A Miller, F Lebel, P R Fortin
Lupus|November 24, 1999
Discordance between patients and their physicians in the assessment of lupus disease activity: relevance for clinical trialsJ C Yen, C Neville, P R Fortin
Arthritis and Rheumatism|August 1, 1995
Measuring relevant change: an emerging challenge in rheumatologic clinical trialsP R Fortin, G Stucki, J N Katz
Pageof 9